Relaxo Footwears Ltd - Weak Demand & Heightened Competition Dent Performance
The company reported disappointing results as demand remained subdued. Relaxo’s revenue de-grew by 5% YoY to Rs 679 Cr, missing our estimates of 5.3%.
124 Views
Relaxo Footwears Ltd. - Looking for Sustained Signs of Recovery
Gross margins improved by 460 bps YoY to 62% due to a 10% YoY reduction in input costs. PAT fell by 21% YoY to Rs 44 Cr in Q1FY25, impacted by...
135 Views
Relaxo Footwears Ltd. - Gradual Recovery to Continue; Maintain Buy
Subdued Performance: The company’s revenue de-grew by ~2% YoY to Rs 747 Cr, owing to the decline in overall volumes, down 4% YoY.
154 Views
Relaxo Footwears Ltd. - SEEING GRADUAL RECOVERY; MAINTAIN BUY
The company’s revenue grew 5% YoY (15% volume growth to 4.7 Cr pairs) as realisation degrew by 7% on account of price cuts. This led to higher...
312 Views
HSIE Results Daily: Sun Pharmaceutical Industries, Prestige Estates, Phoenix Mills
Sun Pharmaceutical Industries: EBITDA grew 10% YoY as sales growth was moderate at 6% YoY (US and global specialty: -2% QoQ, India: +16% YoY) was...
343 Views